Research ArticleConference Proceedings

Proceedings of the 2023 Viral Clearance Symposium, Session 4: Continuous Processing

John Fisher and Scott Lute
PDA Journal of Pharmaceutical Science and Technology March 2024, 78 (2) 169-175; DOI: https://doi.org/10.5731/pdajpst.2024.002244

Article Information

vol. 78 no. 2 169-175
DOI 
https://doi.org/10.5731/pdajpst.2024.002244
PubMed 
38609148
Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online April 12, 2024.
Copyright & Usage 
© PDA, Inc. 2024

Author Information

  1. John Fisher1 and
  2. Scott Lute2,*
  1. 1Process Virology, Purification Development, Genentech, a Member of the Roche Group, 1 DNA Way, South San Francisco, CA 94080; and
  2. 2Center for Drug Evaluation and Research, Office of Product Quality Research, U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993
  1. ↵*Corresponding Author: Center for Drug Evaluation and Research, Office of Product Quality Research, U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993; E-mail: scott.lute{at}fda.hhs.gov
View Full Text

Cited By...

Back to top

In This Issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Proceedings of the 2023 Viral Clearance Symposium, Session 4: Continuous Processing
John Fisher, Scott Lute
PDA Journal of Pharmaceutical Science and Technology Mar 2024, 78 (2) 169-175; DOI: 10.5731/pdajpst.2024.002244
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords